Two Sigma Investments’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.55M | Buy |
376,776
+52,916
| +16% | +$498K | 0.01% | 1417 |
|
|
2025
Q1 | $1.76M | Sell |
323,860
-30,094
| -9% | -$163K | ﹤0.01% | 1772 |
|
|
2024
Q4 | $2.64M | Sell |
353,954
-103,098
| -23% | -$768K | 0.01% | 1474 |
|
|
2024
Q3 | $3.65M | Sell |
457,052
-143,350
| -24% | -$1.15M | 0.01% | 1213 |
|
|
2024
Q2 | $5.22M | Buy |
600,402
+495,512
| +472% | +$4.31M | 0.01% | 941 |
|
|
2024
Q1 | $2.17M | Sell |
104,890
-44,892
| -30% | -$928K | 0.01% | 1367 |
|
|
2023
Q4 | $3.46M | Buy |
149,782
+80,152
| +115% | +$1.85M | 0.01% | 1126 |
|
|
2023
Q3 | $556K | Buy |
+69,630
| New | +$556K | ﹤0.01% | 2156 |
|
|
2023
Q2 | – | Sell |
-54,625
| Closed | -$161K | – | 3001 |
|
|
2023
Q1 | $161K | Sell |
54,625
-21,277
| -28% | -$62.6K | ﹤0.01% | 2526 |
|
|
2022
Q4 | $266K | Buy |
75,902
+63,077
| +492% | +$221K | ﹤0.01% | 2228 |
|
|
2022
Q3 | $101K | Sell |
12,825
-737
| -5% | -$5.8K | ﹤0.01% | 2180 |
|
|
2022
Q2 | $107K | Sell |
13,562
-5,894
| -30% | -$46.5K | ﹤0.01% | 2194 |
|
|
2022
Q1 | $236K | Sell |
19,456
-173,559
| -90% | -$2.11M | ﹤0.01% | 2257 |
|
|
2021
Q4 | $2.36M | Buy |
+193,015
| New | +$2.36M | 0.01% | 1247 |
|
|
2021
Q2 | – | Sell |
-40,592
| Closed | -$412K | – | 2549 |
|
|
2021
Q1 | $412K | Buy |
+40,592
| New | +$412K | ﹤0.01% | 1944 |
|
|
2020
Q2 | – | Sell |
-4,140
| Closed | -$42K | – | 2093 |
|
|
2020
Q1 | $42K | Buy |
+4,140
| New | +$42K | ﹤0.01% | 1793 |
|
|
2019
Q1 | – | Sell |
-1,090
| Closed | -$21K | – | 2213 |
|
|
2018
Q4 | $21K | Buy |
+1,090
| New | +$21K | ﹤0.01% | 2026 |
|
|
2016
Q1 | – | Sell |
-7,602
| Closed | -$366K | – | 2166 |
|
|
2015
Q4 | $366K | Buy |
+7,602
| New | +$366K | ﹤0.01% | 1652 |
|
|
2015
Q1 | – | Sell |
-3,435
| Closed | -$141K | – | 2194 |
|
|
2014
Q4 | $141K | Sell |
3,435
-5,655
| -62% | -$232K | ﹤0.01% | 2105 |
|
|
2014
Q3 | $402K | Buy |
9,090
+6,763
| +291% | +$299K | ﹤0.01% | 1368 |
|
|
2014
Q2 | $101K | Buy |
+2,327
| New | +$101K | ﹤0.01% | 2051 |
|